Cargando…

Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms

OBJECTIVES: The goal of this study was to assess mitochondrial function, energy, and purine metabolism, protein synthesis machinery from the nucleolus to the ribosome, inflammation, and expression of newly identified ectopic olfactory receptors (ORs) and taste receptors (TASRs) in the frontal cortex...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Esparcia, Paula, López-González, Irene, Grau-Rivera, Oriol, García-Garrido, María Francisca, Konetti, Anusha, Llorens, Franc, Zafar, Saima, Carmona, Margarita, del Rio, José Antonio, Zerr, Inga, Gelpi, Ellen, Ferrer, Isidro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346561/
https://www.ncbi.nlm.nih.gov/pubmed/28348546
http://dx.doi.org/10.3389/fneur.2017.00089
_version_ 1782513900279824384
author Garcia-Esparcia, Paula
López-González, Irene
Grau-Rivera, Oriol
García-Garrido, María Francisca
Konetti, Anusha
Llorens, Franc
Zafar, Saima
Carmona, Margarita
del Rio, José Antonio
Zerr, Inga
Gelpi, Ellen
Ferrer, Isidro
author_facet Garcia-Esparcia, Paula
López-González, Irene
Grau-Rivera, Oriol
García-Garrido, María Francisca
Konetti, Anusha
Llorens, Franc
Zafar, Saima
Carmona, Margarita
del Rio, José Antonio
Zerr, Inga
Gelpi, Ellen
Ferrer, Isidro
author_sort Garcia-Esparcia, Paula
collection PubMed
description OBJECTIVES: The goal of this study was to assess mitochondrial function, energy, and purine metabolism, protein synthesis machinery from the nucleolus to the ribosome, inflammation, and expression of newly identified ectopic olfactory receptors (ORs) and taste receptors (TASRs) in the frontal cortex of typical cases of dementia with Lewy bodies (DLB) and cases with rapid clinical course (rpDLB: 2 years or less) compared with middle-aged non-affected individuals, in order to learn about the biochemical abnormalities underlying Lewy body pathology. METHODS: Real-time quantitative PCR, mitochondrial enzymatic assays, and analysis of β-amyloid, tau, and synuclein species were used. RESULTS: The main alterations in DLB and rpDLB, which are more marked in the rapidly progressive forms, include (i) deregulated expression of several mRNAs and proteins of mitochondrial subunits, and reduced activity of complexes I, II, III, and IV of the mitochondrial respiratory chain; (ii) reduced expression of selected molecules involved in energy metabolism and increased expression of enzymes involved in purine metabolism; (iii) abnormal expression of nucleolar proteins, rRNA18S, genes encoding ribosomal proteins, and initiation factors of the transcription at the ribosome; (iv) discrete inflammation; and (v) marked deregulation of brain ORs and TASRs, respectively. Severe mitochondrial dysfunction involving activity of four complexes, minimal inflammatory responses, and dramatic altered expression of ORs and TASRs discriminate DLB from Alzheimer’s disease. Altered solubility and aggregation of α-synuclein, increased β-amyloid bound to membranes, and absence of soluble tau oligomers are common in DLB and rpDLB. Low levels of soluble β-amyloid are found in DLB. However, increased soluble β-amyloid 1–40 and β-amyloid 1–42, and increased TNFα mRNA and protein expression, distinguish rpDLB. CONCLUSION: Molecular alterations in frontal cortex in DLB involve key biochemical pathways such as mitochondria and energy metabolism, protein synthesis, purine metabolism, among others and are accompanied by discrete innate inflammatory response.
format Online
Article
Text
id pubmed-5346561
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-53465612017-03-27 Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms Garcia-Esparcia, Paula López-González, Irene Grau-Rivera, Oriol García-Garrido, María Francisca Konetti, Anusha Llorens, Franc Zafar, Saima Carmona, Margarita del Rio, José Antonio Zerr, Inga Gelpi, Ellen Ferrer, Isidro Front Neurol Neuroscience OBJECTIVES: The goal of this study was to assess mitochondrial function, energy, and purine metabolism, protein synthesis machinery from the nucleolus to the ribosome, inflammation, and expression of newly identified ectopic olfactory receptors (ORs) and taste receptors (TASRs) in the frontal cortex of typical cases of dementia with Lewy bodies (DLB) and cases with rapid clinical course (rpDLB: 2 years or less) compared with middle-aged non-affected individuals, in order to learn about the biochemical abnormalities underlying Lewy body pathology. METHODS: Real-time quantitative PCR, mitochondrial enzymatic assays, and analysis of β-amyloid, tau, and synuclein species were used. RESULTS: The main alterations in DLB and rpDLB, which are more marked in the rapidly progressive forms, include (i) deregulated expression of several mRNAs and proteins of mitochondrial subunits, and reduced activity of complexes I, II, III, and IV of the mitochondrial respiratory chain; (ii) reduced expression of selected molecules involved in energy metabolism and increased expression of enzymes involved in purine metabolism; (iii) abnormal expression of nucleolar proteins, rRNA18S, genes encoding ribosomal proteins, and initiation factors of the transcription at the ribosome; (iv) discrete inflammation; and (v) marked deregulation of brain ORs and TASRs, respectively. Severe mitochondrial dysfunction involving activity of four complexes, minimal inflammatory responses, and dramatic altered expression of ORs and TASRs discriminate DLB from Alzheimer’s disease. Altered solubility and aggregation of α-synuclein, increased β-amyloid bound to membranes, and absence of soluble tau oligomers are common in DLB and rpDLB. Low levels of soluble β-amyloid are found in DLB. However, increased soluble β-amyloid 1–40 and β-amyloid 1–42, and increased TNFα mRNA and protein expression, distinguish rpDLB. CONCLUSION: Molecular alterations in frontal cortex in DLB involve key biochemical pathways such as mitochondria and energy metabolism, protein synthesis, purine metabolism, among others and are accompanied by discrete innate inflammatory response. Frontiers Media S.A. 2017-03-13 /pmc/articles/PMC5346561/ /pubmed/28348546 http://dx.doi.org/10.3389/fneur.2017.00089 Text en Copyright © 2017 Garcia-Esparcia, López-González, Grau-Rivera, García-Garrido, Konetti, Llorens, Zafar, Carmona, del Rio, Zerr, Gelpi and Ferrer. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Garcia-Esparcia, Paula
López-González, Irene
Grau-Rivera, Oriol
García-Garrido, María Francisca
Konetti, Anusha
Llorens, Franc
Zafar, Saima
Carmona, Margarita
del Rio, José Antonio
Zerr, Inga
Gelpi, Ellen
Ferrer, Isidro
Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
title Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
title_full Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
title_fullStr Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
title_full_unstemmed Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
title_short Dementia with Lewy Bodies: Molecular Pathology in the Frontal Cortex in Typical and Rapidly Progressive Forms
title_sort dementia with lewy bodies: molecular pathology in the frontal cortex in typical and rapidly progressive forms
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346561/
https://www.ncbi.nlm.nih.gov/pubmed/28348546
http://dx.doi.org/10.3389/fneur.2017.00089
work_keys_str_mv AT garciaesparciapaula dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT lopezgonzalezirene dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT grauriveraoriol dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT garciagarridomariafrancisca dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT konettianusha dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT llorensfranc dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT zafarsaima dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT carmonamargarita dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT delriojoseantonio dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT zerringa dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT gelpiellen dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms
AT ferrerisidro dementiawithlewybodiesmolecularpathologyinthefrontalcortexintypicalandrapidlyprogressiveforms